Tech Company Financing Transactions
Innovac Therapeutics Funding Round
On 9/4/2023, Innovac Therapeutics announced $18 million in Seed funding from Elikon Venture, TG Sino-Dragon Fund and private investors.
Transaction Overview
Company Name
Announced On
9/4/2023
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to further develop its technology platform and manufacturing capability to advance its lead programs to clinical stage.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
325 Vassar Street 2A
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Innovac Therapeutics is a biotechnology company dedicated to developing innovative vaccines for patients with unmet medical needs, using our proprietary RNA technology platforms and manufacturing capabilities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Zhang
Chief Scientific Officer
Nicholas Valiante
Chief Technical Officer
Hang Yuan
Browse more venture capital transactions:
Prev: 9/4/2023: Stroom venture capital transaction
Next: 9/4/2023: Miri venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs